Instead, adiponectin has a more complex role in rheumatic disorders, and in this study, we established a consistent association between higher adiponectin levels and proteinuria in SLE patients, pointing that this adipokine should be considered as a biomarker of renal involvement in SLE patients. Here, ADIPOQ is linked to systemic lupus erythematosus.